LB Pharmaceuticals Inc Common Stock (LBRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for LB Pharmaceuticals Inc Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -22.34x | -0.97x | -9.76x | -4.27x |
| P/B Ratio | 1.87x | -0.65x | -1.78x | -2.13x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 41.44x | 3.56x | 17.51x | 45.82x |
| Quick Ratio | 41.44x | 3.56x | 17.51x | 45.82x |
| Leverage | ||||
| Debt/Equity | 0.01x | -0.04x | 0.00x | -0.84x |
YoY = year-over-year change. Source: FMP..